M&A Deal Summary

Bausch Health Acquires Durect

On July 29, 2025, Bausch Health acquired life science company Durect for 63M USD

Acquisition Highlights
  • This is Bausch Health’s 22nd transaction in the Life Science sector.
  • This is Bausch Health’s 22nd largest (disclosed) transaction.
  • This is Bausch Health’s 23rd transaction in the United States.
  • This is Bausch Health’s 7th transaction in California.

M&A Deal Summary

Date 2025-07-29
Target Durect
Sector Life Science
Buyer(s) Bausch Health
Deal Type Add-on Acquisition
Deal Value 63M USD
Advisor(s) Locust Walk Partners (Financial)
Orrick (Legal)

Target

Durect

Cupertino, California, United States
Durect is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated DNA methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury. Durect was founded in 1988 and is based in Cupertino, California.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Bausch Health

Laval, Quebec, Canada

Category Company
Sector Life Science
Employees20,270
Revenue 9.6B USD (2024)
DESCRIPTION

Bausch Health is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of dermatology, neurology, and branded generics. Bausch Health is based in Laval, Quebec.


DEAL STATS #
Overall 36 of 36
Sector: Life Science M&A 22 of 22
Type: Add-on Acquisition M&A Deals 26 of 26
State: California M&A 7 of 7
Country: United States M&A 23 of 23
Year: 2025 M&A 1 of 1
Size (of disclosed) 22 of 28
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-31 Amoun Pharmaceutical Company

Cairo, Egypt

Amoun Pharmaceutical Company is a developer, manufacturer, marketer, distributer, and export of a wide range of human pharmaceutical and animal health products. Amoun Pharmaceutical Company is based in Cairo, Egypt.

Sell $740M